We are proud to see Rik Gijsbers and Marianne Carlon (KU Leuven) deliver a keynote at the RegMed XB 4th Annual Conference in Utrecht, showcasing LifeLUNG's vision and progress. Their presentation covered the full spectrum, from cutting-edge gene therapy vectors and living lung disease models to a clear-eyed roadmap for clinical translation. It was a masterclass in how to build not just a therapy, but an entire ecosystem around it. Thank you both for representing LifeLUNG so

🫁 A lung. Alive. Outside the body. This is made possible by Ex Vivo Lung Perfusion (EVLP), a technology that keeps donor lungs warm, ventilated, and functioning outside the body before transplantation. Using EVLP, clinicians can assess, preserve, and even treat donor lungs before they are transplanted into a patient. At LifeLUNG, we're taking that technology further. In our ongoing research, we are developing EVLP into a more advanced treatment platform, with two specific go